Contrast-enhanced MRI of the breast: Accuracy, value, controversies, solutions

European Journal of Radiology

Volumn 24, Issue 2, 1997, Pages 94-108

  Heywang Kobrunner S H ^a   Viehweg, P ^a   Heinig, A ^a   Kuchler Ch ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

accuracy; breast; contrast enhancement; MRI

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ARTIFACTS; BIOPSY; BREAST DISEASES; BREAST IMPLANTS; BREAST NEOPLASMS; CICATRIX; CONTRAST MEDIA; COSTS AND COST ANALYSIS; ESTROGEN REPLACEMENT THERAPY; FALSE POSITIVE REACTIONS; FEMALE; GERMANY; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MENSTRUAL CYCLE; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNOLOGY, RADIOLOGIC;

EID: 0031080698     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(96)01142-4     Document Type: Article

References (73)

1. [1] Heywang SH, Hahn D, Schmid H et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986; 10: 199-204.
2. [2] Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170: 681-686.
3. [3] Stack JP, Redmond V, Codd MB et al. Breast Disease: Tissue characterisation with Gd-DTPA-enhancement profiles. Radiology 1990; 174: 491-494.
4. [4] Lewis Jones HG, Whitehouse GH, Leinster SJ. The role of MRI in the assessment of local recurrent breast carcinoma. Clin Radiol 1991; 43: 19.
5. [5] Harms SE, Flaming DP, Hesley KL et al. MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation. Radiology 1993; 187: 493.
6. [6] Hachiya J, Seki T, Okada M. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography. Radiat Med 1991; 9: 232-240.
7. [7] Fischer U, v. Heyden D, Vosshenrich R et al. Signal/time relation of malignant and nonmalignant lesions in contrast-enhanced MR imaging of the breast. Roe Fo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahren 1993; 158: 287-292.
8. [8] Gilles R, Guinebretiere J, Lucidarme O et al. Non-palpable breast tumors: diagnosis with contrast-enhancend subtraction dynamic MR imaging. Radiology 1994; 191: 625-631.
9. [9] Oellinger H, Hems S, Sander B et al. Gd-DTPA enhanced MR breast imaging: the most sensitive method for multicentric carcinomas of the female breast. Eur Radiol 1993; 3/3: 223.
10. [10] Orel SG. Schnall MD, Powell CM et al. Staging of suspected breast cancer: effect of MR imaging and MR guided biopsy. Radiology 1995; 196: 115-122.
11. [11] Boetes C, Barentz JO, Mus RD et al. MR characterisation of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994; 193; 777-81.
12. [12] Bone B, Aspelin P, Isberg B et al. Contrast-enhanced MRI of the breast in patients with breast implants after cancer surgery. Acta Radiol 1995; 36: 111-115.
13. [13] Kuhl CK, Seibert C, Kneft BP et al. Focal and difluse contrast enhancement in dynamic MR Mammography of healthy volunteers. Radiology 1994; 193 (P): 121.
14. [14] Klengel S, Hietschold V, Schreiber M, Köhler K. Qualitative kontrastmitteldynamische Mamma-MRT am 0,5-Tesla-Gerät. Röntgenpraxis 1994; 47: 223-228.
15. [15] Knopp MV, Junkermann HI, Heß T et al. MR-Mammographie zum Monitoring von neoadjuvanter Therapie beim Mammakarzinom. der Radiologe 1995; 35/4: 81.
16. [16] Kaiser WA. MRM promises earlier breast cancer diagnosis. Diagn Imaging Clin Med 1992; 88-93.
17. [17] Terao E, Takeuchi H, Iwamura A et al. Ability of subtraction and dynamic MR imaging to detect breast tumors: comparison with ultrasonography and mammography. Nippon-Igaku-Hoshusen-Gakkai-Zasshi 1994; 54 (10): 950-957.
18. [18] Heywang SH, Hilbertz T, Pruss E et al. Dynamische Kontrastmitteluntersuchungen mit FLASH bei Kernspintomographie der Mamma. Digitale Bilddiagnostik 1988; 7-13.
19. [19] Heywang-Köbrunner SH. Contrast-enhanced MRI of the Breast. München: Karger 1990.
20. [20] Heywang-Köbrunner SH, Viehweg P. Sensitivity of contrast-enhanced MR imaging of the breast. In: Davis PL., ed. Magnetic Resonance Imaging Clinics of North America. Breast Imaging 1994; 2 (4): 527-536.
21. [21] Heywang-Köbrunner SH, Beck R. Contrast-enhanced MRI of the Breast. New York: Springer 1996.
22. [22] Van Dijck JAAM, Verbeek ALM, Hendriks IHCL, Holland R. The current detectability of breast cancer in a mammographic screening programm. Cancer 1993; 72: 1933.
23. [23] Harvey JA, Fajardo LL, Inhis CA. Previous mammograms in patients with impalpable breast carcinoma: retrospective versus blinded interpretation. AIR 1993; 161: 1167.
24. [24] Bird RE, Wallace TW. Yankaskas BC. Analysis of cancers missed at screening mammography: Radiology 1992; 184: 613.
25. [25] Tabar L, Fagerberg G, Day NE et al. Breast cancer treatment and natural history: new insights from results of Screening. Lancet 1992 Feb 15; 339: 412.
26. [26] Balu-Maestro C, Bruneton JN, Geoffray A et al. Ultrasonographic posttreatment follow-up of breast cancer patients. J Ultrasound Med 1991; 10: 1-7.
27. [27] Ciatto S, Roselli-del-Turco M, Catarzis et al. The diagnostic role of breast echography. Radiol-Med (Torino) 1994; 88 (3): 221.
28. [28] Potterton AJ, Peakman DJ, Young IR. Ultrasound demonstration of small breast cancers detected by mammographic screening. Clin Radiol 1994; 49 (11): 808.
29. [29] Pamilo M, Soiva M, Anttinen I et al. Ultrasonography of breast lesions detected in mammography screening. Acta Radiol 1991; 32: 220.
30. [30] Dronkers DJ. Stereotaxic core biopsy of breast lesions. Radiology 1992; 183: 631.
31. [31] Dempsey P, Rubin E. The roles of needle biopsy and periodic follow up in the evaluation and diagnosis of breast lesions. Semin Roentgenol 1993; 28: 252.
32. [32] Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology 1993; 188: 453.
33. [33] Liberman L, Dershaw DD, Rosen PP et al. Stereotaxic 14-gauge breast biopsy. How many core biopsy specimens are needed? Radiology 1994; 192: 793-795.
34. [34] Parker SH, Burbank F, Jackmann RJ et al. Percutaneous large-core breast biopsy: a multunstitutional study. Radiology 1994; 193: 359.
35. [35] Dresel V, Buhner M, Schulz-Wendtland R, Bauer M. Intraduktale Karzinome der Mamma ist eme Diagnose in der Kernspintomographie möglich? Radiologe 1995; 35 (4): 87.
36. [36] Frouge C. Guinebretiere JM, Contesso G et al. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994; 29 (12): 1043-1049.
37. [37] Ottinetti A, Sapino A. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res Treat 1988; 11 (3): 241-8.
38. [38] Samejima N, Yamazaki K. A study on the vascular proliferation in tissues around the tumor in breast cancer. Jpn J Surg 1988; 18 (3): 235-42.
39. [39] Allgayer B, Imhof M, Kutschker C, Nathrath W (1995a). Dynamische MRT Untersuchungen von Mammatumoren Vergleich: Kontrastenhancement vs. Vaskularisationsgrad. Radiologe 1995; 4 (1): 83.
40. [40] Fischer U, Brinck U, Korabiowska M et al. The prognostic value of contrast-enhanced dynamic MR mammography in breast cancer. Europ Radiol 1997, in press.
41. [41] Connolly DT, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84 (5): 1470-1478.
42. [42] Lykke AWJ, Cuminings R. Inflammation in healing. Time-Course and mediation of exsudation in wound healing in the rat. J Exp Pathol 1969; 50: 309-318.
43. [43] Nagy JA, Brown LF, Senger DR et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1989; 948: 305-326.
44. [44] Vaupel PW. Blood Flow, oxygenation, tissue pH distribution and bioenergetic status of tumors. Berlin: Hellmich 1994.
45. [45] Blood CH, Zetter BR. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032: 89-118.
46. [46] Jensen HM, Chen J, De Vault MR, Lewis AE. Angiogenesis induced by 'normal' human breast tissue: a probable marker for precancer. Science 1982; 218: 293-295.
47. [47] Weidner, N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324 (1): 1-8.
48. [48] Empfehiungen des Ausschusses Magnetresonanztomographie für Qualitätsanforderungen MRT der Mamma [Recommendations for MRI of the Breast], issued by Deutsche Röntgengesellschaft, Bad-Homburg 1994 und 1996.
49. [49] Heywang-Köbrunner SH, Beck R, Heinig A et al. Vorstellung emes Kompressoriums for Mamma-MRT. Roe Fo 1996; 164: 86.
50. [50] Heywang-Köbrunner SH, Haustein J, Pohl C, Beck R, Lommatzsch B, Untch M, Nathrath WBI. Contrast-enhancend MRI of the breast - comparison of two dosages of Gd-DTPA. Radiology 1994; 191: 639-646.
51. [51] Heywang-Köbrunner SH, Wolf HD, Deimling M et al. Misleading changes of the signal intensity on opposed phase images after injection of contrast medium. 1996; 20 (2): 173-178.
52. [52] Beck, R. Heywang-Köbrunner SH, Untch M. Contrast-enhancement of proliferative dysplasia in MRI of the breast due to the menstrual cycle. In: Peters PE, ed. European Congress of Radiology 93 (Book of abstracts). New York: Springer 1993: p. 151.
53. [53] Patt RH, Ascher S, Goldberg J et al. Dynamic contrast-enhanced MR imaging of the normal breast during the menstrual cycle. JMRI 1994; 4 (P): 89.
54. [54] Flickinger FW, Allison JD, Sherry R et al. Differentiation of benign from malignant breast masses by dynamic time - intensity evaluation of contrast-enhanced MRI. Proc. Annu. Meet. Soc. Magnetic Resonance in Medicine. SMRM, Berkeley (Book of Abstracts) 1992: 955.
55. [55] Fischer U, Westerhoff HP, Brinck U et al. Das Erscheinungsbild des duktalen Carcinoma in situ in der dynamischen MR-Mammographic. Roe Fo Fortschr Geb Rontgenstr Neuen Bildg Verfahr 1996; 164: 290.
56. [56] Zapf S, Halbsguth A, Brunier A et al. Möglichkeiten der MRT in der Diagnostik nicht-palpabler Mammatumoren. Roefo 1991; 154 (1): 106-110.
57. [57] Boetes C. Magnetic resonance imaging of breast cancer, a clinical study. Doktorarbeit an der Katholischen Universität Nimwegen. Ianssen Print Nimwegen 1995.
58. [58] Heywang-Köbrunner SH, Hilbertz T, Beck R et al. Contrast-material enhanced MRI of the breast in patients with postoperative scarring and silicon implants. J Comput Assist Tomogr 1990; 14 (3): 348-356.
59. [59] Fischer U, Vosshenrich R, Probst A et al. Preoperative MR mammography in patients with breast cancer - useful information or useless extravagance. Roe Fo 1994; 161 (4): 300-306.
60. [60] Tontsch P, Bauer M, Schulz-Wendtland R et al. Dynamische MR-Mammographie bei 160 Hochrisikopatientinnen, der Radiologe 1995; 35 (4): 83.
61. [61] Allgayer B, Hauck W. Jänicke F et al. MRT-Diagnostik von Mammakarzinomen mit emem nicht-ionischen Kontrastmittel in 2D- und 3D-Gradientenecho-FFE-Technik. der Radiologe 1995; 35 (4): 84.
62. [62] Buchberger W, Kapfer M, Stöger A et al. Dignitätsbeurteilung fokaler Mammalasionen: prospektiver Vergleich von Mammographie, Sonographie und dynamischer MRT. der Radiologe 1995; 35 (4) (1): 86.
63. [63] Sittek H, Kessler M, Brendi T, Reiser M. Dynamische FLASH-3D MR-Mammographie-Vergleich mit standardisierter Mammographie. der Radiologe 1995; 35 (4): 199.
64. [64] Knopp M V, HeB T, Junkermann HJ et al. Diagnostischer Stellenwert der MR-Mammographie bei nicht palpablen durch Vorsorgeuntersuchung detektierten Herden. der Radiologe 1995; 35 (4): 81.
65. [65] Dao TH, Rahmouni A, Campana F et al. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhancend MR imaging. Radiology 1993; 187 (3): 751-755.
66. [66] Heywang-Köbrunner SH, Schiegel A, Beck R et al. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. ICAT 1993; 17: 891.
67. [67] Kurtz B, Audretsch W, Rezai M et al. Erste Erfahrungen mit der MR-Mammographie bei lappenunterstutzter operativer Behandlung des Mammakarzinoms. Roe Fo 1996; 164 (4): 295-300.
68. [68] Degani H, Fields S, Catane R et al. Evaluation of breast cancer therapy with contrast-enhanced MRI at high spatial resolution. J Magn Reson Imag 1994; 4 (P): 116.
69. [69] Gilles R. Guinebretiere J, Toussaint C et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994; 191: 633-638.
70. [70] Przetak C, Audretsch W, Schnabel T et al. Therapie-Monitoring des MammaCarcinoms durch Kernspintomographie bei neoadjuvanter Therapie. der Radiologe 1995; 35 (4) (1): 581.
71. [71] Rieber A, Tomczak R, Rosenthal H et al. Mamma-MRT nach chemotherapierten Mammakarzinomen. der Radiologe 1995; 35 (4): 82.
72. [72] Kurtz B, Achten C. Audretsch W et al. MR-mammographische Beurteilung des Tumoransprechverhaltens nach neoadjuvanter Radiochemotherapie lokal fortgeschrittener Mammakarzinome. Roe Fo 1996; 164 (6): 469-74.
73. [73] Maass H. Mammakarzinom: Epidemiologie. Gynakologie 1994; 27: 3-6.